WPG Advisers’s RxSight RXST Stock Holding History

WPG Advisers’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-35	Closed	-$1.2K	–	1525
2024 Q4	$1.2K	Buy	+35	New	+$1.58K	﹤0.01%	1197

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

WPG Advisers's RXST Position: Q1 2025 in Review

WPG Advisers sold out of RxSight (RXST) in Q1 2025, closing a stake of 35 shares — an estimated $1.2K sold.

WPG Advisers first reported a position in RXST in Q4 2024 and held it in 1 quarter. The position peaked at $1.2K in Q4 2024. 192 funds tracked by Wall St. Rank hold RXST as of Q1 2025.

WPG Advisers reported no remaining RxSight position as of Q1 2025 after selling out during the quarter.
WPG Advisers sold 35 RxSight shares in Q1 2025, an estimated $1.2K.
WPG Advisers first reported a position in RxSight in Q4 2024 and held it in 1 quarter.
WPG Advisers's RxSight position peaked at $1.2K in Q4 2024.
192 funds tracked by Wall St. Rank held RxSight as of Q1 2025.

Based on WPG Advisers's 13F filing for Q1 2025, filed 15 May 2025.